Table 3.
Variable | BE Group |
NS Group |
P | ||
---|---|---|---|---|---|
(n = 68) | (n = 64) | ||||
PACU analgesic, n (%) | 68 | 64 | .92 | ||
Fentanyl | 12 (18) | 12 (19) | |||
Fentanyl + oxycodone | 28 (41) | 25 (39) | |||
Fentanyl + other | 7 (10) | 4 (6) | |||
Oxycodone | 9 (13) | 8 (13) | |||
Oxycodone + other | 0 (0) | 1 (1) | |||
None | 10 (15) | 10 (16) | |||
Other | 2 (3) | 4 (6) | |||
PACU antiemetic | 68 | 32 (47) | 64 | 24 (38) | .27 |
PACU fentanyl dose, μg (range)* | 47 | 100 [50–100] | 41 | 100 (50–100) | .58 |
PACU oxycodone dose, mg (range)* | 37 | 10 [5–10] | 33 | 10 (5–10) | .51 |
Postoperative days on narcotics, n (range)† | 62 | 2 (0–11) | 59 | 3 (0–14) | .26 |
Postoperative days on OTC analgesics, n (range)† | 62 | 2 (0–14) | 58 | 3 (0–14) | .32 |
14-Day postoperative number of narcotic tablets (mean ± SD)* | 63 | 8.48 ± 1.02 | 60 | 11.72 ± 1.48 | 0.07 |
14-Day postoperative number of OTC tablets‡ | 63 | 13.14 ± 2.59 | 60 | 11.20 ± 2.27 | 0.57 |
OTC, over-the-counter. All data are n (%), unless otherwise specified.
*Median [q1, q3];
†median (range);
‡mean ± SE (from negative binomial model).